Campylobacter at the Human–Food Interface: The African Perspective
| Autor: | Sam Abraham, Angela Parry-Hanson Kunadu, Nikki Asuming-Bediako, Ihab Habib |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2019 |
| Předmět: |
0301 basic medicine
Microbiology (medical) medicine.medical_specialty Animal food 030106 microbiology Developing country Campylobacteriosis lcsh:Medicine Context (language use) Review medicine.disease_cause 03 medical and health sciences one health Antibiotic resistance Environmental health Epidemiology medicine Immunology and Allergy antimicrobial resistance Molecular Biology General Immunology and Microbiology Campylobacter lcsh:R developing countries medicine.disease zoonoses 030104 developmental biology Infectious Diseases One Health Geography campylobacteriosis |
| Zdroj: | Pathogens, Vol 8, Iss 2, p 87 (2019) Pathogens |
| ISSN: | 2076-0817 |
| Popis: | The foodborne pathogen Campylobacter is a major cause of human gastroenteritis, accounting for an estimated annual 96 million cases worldwide. Assessment of the true burden of Campylobacter in the African context is handicapped by the under-reporting of diarrhoeal incidents and ineffective monitoring and surveillance programmes of foodborne illnesses, as well as the minimal attention given to Campylobacter as a causative agent of diarrhoea. The present review of the literature highlights the variability in the reported occurrence of Campylobacter in humans and animal food sources across different countries and regions in Africa. Campylobacter infection is particularly prevalent in the paediatric population and has been isolated from farm animals, particularly poultry, and foods of animal origin. The reported prevalence of Campylobacter in children under the age of five years ranges from 2% in Sudan to 21% in South Africa. In poultry, the prevalence ranges from 14.4% in Ghana to 96% in Algeria. This review also highlights the alarming trend of increased Campylobacter resistance to clinically important antimicrobials, such as ciprofloxacin and erythromycin, in humans and food animals in Africa. This review adds to our understanding of the global epidemiology of Campylobacter at the human−food animal interface, with an emphasis from the African perspective. Interinstitutional and intersectoral collaborations, as well as the adoption of the One Health approach, would be useful in bridging the gaps in the epidemiological knowledge of Campylobacter in Africa. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|